Safety and efficacy of low-dose topical atropine for slowing down progression of myopia in children and adolescents
Aim The aim of this study was to evaluate the safety and efficacy of low-dose (0.01%) topical atropine eye drops for slowing down the progression of myopia in children and adolescents. Patients and methods A total of 600 eyes of 300 patients aged from 8 to 14 years were included in the study. They w...
Main Authors: | Ahmed A Alhagaa, Nermeen M Badawi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Delta Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.djo.eg.net/article.asp?issn=1110-9173;year=2021;volume=22;issue=1;spage=63;epage=67;aulast=Alhagaa |
Similar Items
-
The Role of Atropine in Preventing Myopia Progression: An Update
by: Alberto Chierigo, et al.
Published: (2022-04-01) -
The Effectiveness and Tolerability of Atropine Eye Drops for Myopia Control in Non-Asian Regions
by: Dovile Simonaviciute, et al.
Published: (2023-03-01) -
Atropine in the treatment of childhood myopia
by: Sanitha Sathyan
Published: (2019-01-01) -
The diluted atropine for inhibition of myopia progression in Korean children
by: Ji-Sun Moon, et al.
Published: (2018-10-01) -
Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis
by: Congling Zhao, et al.
Published: (2020-12-01)